Recruit the best talents in Life Sciences to help your company grow and reach your goals
argenx Announces U.S. Food and Drug Administration (FDA) Approval of VYVGART™ (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis
Agomab Therapeutics to Acquire Origo Biopharma
Utrecht Cell Therapy Facility
Utrecht Cell Therapy Facility: a national hub for ATMP development and Cellular Therapy in the Netherlands
NTRC Precision Medicine Services is now Oncolines
As an independent company, Oncolines will now be singularly focused on offering the best precision medicine services in oncology and cancer immunotherapy for our clients.